Preview

Rational Pharmacotherapy in Cardiology

Advanced search

THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY

https://doi.org/10.20996/1819-6446-2010-6-5-685-690

Full Text:

Abstract

Details of the management of patients receiving oral anticoagulants (vitamin K antagonists) for a long time and needed in dental treatment are discussed. Assessment of bleeding and thromboembolism risk in the perioperative continuation or termination of warfarin therapy is shown. Potential of the local hemostatic agents is specified. Modifications of the patient dental health card are offered to prevent complications associated with blood clotting disorders.

About the Authors

T. V. Kozlova
I.M. Sechenov First Moscow State Medical University
Russian Federation
Trubetskaya ul. 8/2, Moscow, 119991


I. M. Makeyeva
I.M. Sechenov First Moscow State Medical University
Russian Federation
Trubetskaya ul. 8/2, Moscow, 119991


V. Y. Doroshina
I.M. Sechenov First Moscow State Medical University
Russian Federation
Trubetskaya ul. 8/2, Moscow, 119991


S. I. Bokareva
I.M. Sechenov First Moscow State Medical University
Russian Federation
Trubetskaya ul. 8/2, Moscow, 119991


References

1. Young K.M. Laboratory medicine: Yesterday, Today, Tomorrow. Vet Clin Path 2005; 34(1):76.

2. Singer D.E, Albers G., Dalen J.E. et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl):546S–592S.

3. Kearon C., Kahn S.R., Agnelli G. et al. Antithrombotic therapy for venous thromboembolic disease:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 454S–545S.

4. Lim W., Wang M., Crowther M., Douketis J. The management of anticoagulated patients requiring dental extraction: a cross-sectional survey of oral and maxillofacial surgeons and hematologists. J Thromb Haemost 2007; 5(10):2157-9.

5. Linnebur S.A., Ellis S., Astroth J.D. Educational practices regarding anticoagulation and dental procedures in US dental schools. J Dent Educ 2007;71(2):296-303.

6. Ward B.B., SmithM.H.Dentoalveolar procedures forthe anticoagulated patient: literature recommendations versus current practice. J Oral Maxillofac Surg 2007; 65(8):1454-60.

7. Douketis J.D. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 2002; 108(1):3-13.

8. Dugdale M., Smith R.M. The patient with bleeding problems. Dent Clin North Am 1983;27(2): 271-88.

9. Patton L.L., Ship J.A. Treatment of patients with bleeding disorders. Dent Clin North Am 1994;38(3): 465-82.

10. Douketis J.D., Berger P.B., Dunn A.S. et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl):299S–339S.

11. Perry D.J., Noakes T.J., Helliwell P.S. Guidelines for the management of patients on oral anticoagulants requiring dental surgery. British Dental Journal 2007; 203(7): 389-393.

12. Ziffer A.M., Scopp I.W., Beck J. et al. Profound bleeding after dental extractions during dicumarol therapy. N Engl J Med 1957; 256(8): 351-353.

13. Al-Mubarak S., Rass M.A.,Alsuwyed A. et al. Thromboembolic risk and bleeding in patients maintaining or stoppingoral anticoagulanttherapyduringdental extraction.J ThrombHaemost2006;4(3):689-691.

14. Randall C. Surgical management of the primary care dental patient on warfarin. Dent Update 2005; 32(7): 414-416, 419-420, 423-424.

15. Wahl M J. Dental surgery in anticoagulated patients. Arch Intern Med 1998; 158(15): 1610-1616.

16. Devani P., Lavery K.M., Howell C.J. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary? Br J Oral Maxillofac Surg 1998; 36(2): 107-111.

17. Campbell J.H., Alvarado F., Murray R.A. Anticoagulation and minor oral surgery: should the anticoagulation regimen be altered? J Oral Maxillofac Surg 2000; 58(2): 131-136.

18. Evans I.L., Sayers M.S., Gibbons A.J. et al. Can warfarin be continued during dental extraction? Re￾sults of a randomized controlled trial. Br J Oral Maxillofac Surg 2002; 40(3): 248-252.

19. Sacco R, Sacco M, Carpenedo M., Moia M. Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets. J Thromb Haemost 2006; 4(3): 688-689.

20. Nematullah A, Alabousi A, Blanas N. et al. Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. Tex Dent J 2009;126(12):1183-93.

21. Sindet-Pedersen S. Distribution of tranexamic acid to plasma and saliva after oral administration and mouth rinsing: a pharmacokinetic study. J Clin Pharmacol 1987; 27(12): 1005-1008.

22. Blinder D., Manor Y., Martinowitz U. et al. Dental extractions in patients maintained on continued oral anticoagulant: comparison of local hemostatic modalities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88(2): 137-140.

23. Blinder D., Manor Y., Martinowitz U., Taicher S. Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding. Int J Oral Maxillofac Surg 2001; 30(6): 518-521.

24. Zanon E., Martinelli F., Bacci C. et al. Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood Coagul Fibrinolysis 2003; 14(1): 27-30.

25. Sindet-Pedersen S., Ramstrom G., Bernvil S., Blomback M.Hemostatic effect oftranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 1989; 320(13): 840-843.

26. Carter G., Goss A. Tranexamic acid mouthwash – a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg 2003; 32(5): 504-507.

27. Stading J.A., Skrabal M.Z., FaulknerM.A. Seven cases ofinteraction betweenwarfarin and cyclooxygenase- 2 inhibitors. Am J Health Syst Pharm 2001;58(21):2076-2080.

28. Gould F.K., Elliott T.S., Foweraker J. et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2006; 57(6): 1035-1042.

29. Garcia D.A., Regan S., Henault L.E. et al. Risk of Thromboembolism With Short-term Interruption of Warfarin Therapy. Arch Intern Med 2008;168(1):63-69

30. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 29 [Epub ahead of print].

31. Kovacs M.J., Kearon C., Rodger M. et al. Single-arm study of bridging therapy with low-molecularweight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004;110(12):1658-1663

32. Douketis J.D., Johnson J.A., Turpie A.G. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004;164(12): 1319-1326.

33. McBane R.D., Wysokinski W.E., Daniels P.R. et al. Periprocedural Anticoagulation Management of Patients With Venous Thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology 2010;30(3):442-448.

34. Hong C.H., Napeñas J.J., Brennan M.T. et al. Frequency of bleeding following invasive dental procedures in patients on low-molecular-weight heparin therapy. J Oral Maxillofac Surg. 2010;68(5): 975-9.

35. Murphy J., Twohig E., McWilliams S.R. Dentists' approach to patients on anti-platelet agents and warfarin: a survey of practice. J Ir Dent Assoc 2010;56(1):28-31.

36. Mehra P., CottrellD.A., Bestgen S.C., Booth D.F. Management of heparin therapy in the high-risk, chronically anticoagulated oral surgery patient: a review and a proposed nomogram. J Oral Maxillofac Surg 2000;58(2):198-202.


For citation:


Kozlova T.V., Makeyeva I.M., Doroshina V.Y., Bokareva S.I. THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY. Rational Pharmacotherapy in Cardiology. 2010;6(5):685-690. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-5-685-690

Views: 362


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)